Coldstream Capital Management Inc Acadia Pharmaceuticals Inc Call Options Transaction History
Coldstream Capital Management Inc
- $5.98 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
351Shares Held
164MCall Options Held
751KPut Options Held
274K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.02 Billion9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$360 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$286 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$213 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$147 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.84B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...